# The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole

> **NCT04547335** · — · UNKNOWN · sponsor: **Dokuz Eylul University** · enrollment: 34 (estimated)

## Conditions studied

- Adverse Drug Reactions

## Interventions

- **DRUG:** Voriconazole

## Key facts

- **NCT ID:** NCT04547335
- **Lead sponsor:** Dokuz Eylul University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-10-31
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2020-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04547335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04547335, "The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04547335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*